Could a nerve drug help botulism patients breathe easier?

NCT ID NCT01441557

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This small pilot study tested a drug called 3,4-diaminopyridine (FIRDAPSE) in 3 people with severe botulism who needed a ventilator to breathe. The goal was to see if the drug could improve nerve signals and breathing. Because only 3 people took part, the results are very preliminary and not enough to draw firm conclusions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

3,4-diaminopyridine (FIRDAPSE)

What this could lead to

If it works, this drug could help botulism patients breathe better and recover muscle function faster.

What could go wrong

This was a tiny pilot study with only 3 participants, so results may not apply widely. The drug may cause side effects like seizures or heart issues.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BOTULISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

botulism

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU

    Amiens, 80000, France